Call us today at 1-562-432-0111

© 2016 by Cardiovascular Innovation and Research Center, Inc. All Rights Reserved.

CIRC, Inc News & Views 

First Open Heart Surgery in Long Beach gave man 60 years and more...

February 14, 2017

Sixty years ago, doctors performed open-heart surgery on a 12-year-old boy at what was then called St. Mary Medical Center.

It was the first open-heart surgery done in Long Beach. The patient, Mike Rivard, was given a 25 percent chance of survival.

On Valentine’s Day, Rivard celebrated turning 72 with his wife, kids and grandkids plus about 50 other seniors at a lunch at the hospital, now Dignity Health St. Mary Medical Center.

By Antonie Boessenkool

Long Beach Press-Telegram

In Technological Age, Men Encouraged To Stay Mobile, Get Health Checkups And Make Lifestyle Changes

June 06, 2016

In Technological Age, Men Encouraged To Stay Mobile, Get Health Checkups And Make Lifestyle Changes

June 6, 2016

Sean Belk, Staff Writer

Long Beach Business Journal

Dr. Nikhil Kapoor: Super Doctors 2019!

June 01, 2016

Our Cardiologist, Dr. Nik Kapoor who has attained an outstanding degree of peer recognition and numerous professional achievements is currently listed in the Super Doctors listing (2016-2019) and was a Southern California Rising Star (2013 and 2014).

Small adjustments, big improvements in women's heart health: doctors

February 23, 2013

Feeling tired, stressed out, short of breath, women often disregard some very telling symptoms because there's just so much to do. But improving your heart health doesn't take much. Doctors say that for women, small adjustments can change their hearts.

What's this item about? What makes it interesting? Write a catchy description to grab your audience's attention...

By Denise Dador

ABC7 Eyewitness News

NIH launches trial to evaluate anti-inflammatory treatment for preventing heart attacks, strokes, and cardiovascular deaths

August 22, 2012

An international multi-site trial has launched to determine whether a common anti-inflammatory drug can reduce heart attacks, strokes, and deaths due to cardiovascular disease in people at high risk for them. This study is being supported by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health.

Inflammation, along with high blood pressure and high cholesterol, plays a major role in heart attack and stroke. The Cardiovascular Inflammation Reduction Trial (CIRT) will determine whether treatment with a drug specifically targeting inflammation reduces rates of cardiovascular events among adults who have had a heart attack within the past five years and who also have type 2 diabetes or metabolic syndrome. The trial will randomly assign participants to receive methotrexate given at 10 to 20 milligrams weekly for three to four years or a placebo. Methotrexate is an inexpensive generic drug commonly used at low doses to treat rheumatoid arthritis. It is also used at higher doses to treat certain forms of cancers such as leukemias and lymphomas.

Please reload